Navigation Links
Mandate for public access to NIH-funded research poised to become law
Date:10/24/2007

Washington, D.C. October 24, 2007 - The U.S. Senate last night approved the FY2008 Labor, HHS, and Education Appropriations Bill (S.1710), including a provision that directs the National Institutes of Health (NIH) to strengthen its Public Access Policy by requiring rather than requesting participation by researchers. The bill will now be reconciled with the House Appropriations Bill, which contains a similar provision, in another step toward support for public access to publicly funded research becoming United States law.

Last nights Senate action is a milestone victory for public access to taxpayer-funded research, said Heather Joseph, Executive Director of SPARC (the Scholarly Publishing and Academic Resources Coalition, a founding member of the ATA). This policy sets the stage for researchers, patients, and the general public to benefit in new and important ways from our collective investment in the critical biomedical research conducted by the NIH.

Under a mandatory policy, NIH-funded researchers will be required to deposit copies of eligible manuscripts into the National Library of Medicines online database, PubMed Central. Articles will be made publicly available no later than 12 months after publication in a peer-reviewed journal.

The current NIH Public Access Policy, first implemented in 2005, is a voluntary measure and has resulted in a deposit rate of less than 5% by individual investigators. The advance to a mandatory policy is the result of more than two years of monitoring and evaluation by the NIH, Congress, and the community.

We thank our Senators for taking action on this important issue, said Pat Furlong, Founding President and CEO of Parent Project Muscular Dystrophy. This level of access to NIH-funded research will impact the disease process in novel ways, improving the ability of scientists to advance therapies and enabling patients and their advocates to participate more effectively. The advance is ti
'/>"/>

Contact: Jennifer McLennan
jennifer@arl.org
202-296-2296
SPARC
Source:Eurekalert

Page: 1 2

Related biology news :

1. New push for public health, AIDS spending at African Union summit
2. Wiley announces publication of Databasing the Brain
3. BioMed Central welcomes the new National Institutes of Health public access policy
4. Not-for-profit publishers call NIH public access rule a missed opportunity
5. NIH Calls on Scientists to Speed Public Release of Research Publications
6. CoPub Mapper: mining MEDLINE based on search term co-publication
7. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
8. DOE JGI launches IMG public online microbial genome data clearinghouse
9. Understanding biases in epidemic models important when making public health predictions
10. Does manganese inhaled from the shower represent a public health threat?
11. Public collections of DNA and RNA sequence reach 100 gigabases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ntain forest,s woodland herb population has shown ...ories recover from logging, according to Purdue Un...rtions of the forest nearly 80 years ago, the dist...t floor was similar to that of undisturbed areas. ...orestry and natural resources, said that contrasts...
(Date:12/2/2009)...nter researchers have figured out how stem cells i...able to resist radiation therapy. And using a drug...cancer stem cells, they were able to kill many mor...riment. , The work builds off earlier research ...ects of radiation much better than other cancer ce...
(Date:12/2/2009)...roduct called moist snuff placed between lip and ...obacco industry to change manufacturing practices ...udy is published online in ACS, monthly journal C...his category of tobacco products contains surprisi...ng substances. Called polycyclic aromatic hydrocar...
Breaking Biology News(10 mins):Study finds logging effects vary based on a forest's history, climate 2Discovery makes brain tumor cells more responsive to radiation 2INV102 Asthma Product Discussed at the European Respiratory Society 14206 1INV102 Asthma Product Discussed at the European Respiratory Society 14206 2ESMO recognizes centers of excellence in palliative care for cancer patients 57956 1ESMO recognizes centers of excellence in palliative care for cancer patients 57956 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 1NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 3NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 4NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 5
..., Nitrogen pollution from agriculture and fossil ... in the UK. A new European study is starting to sh... current policies to protect ecosystems may need a...in 2004, her findings were so significant they wer...elected as contributing to one of the top ten scie...
..., Athens, Ga. For the estimated millions of AIDS...oping resistance to currently available medicines,... may offer a new treatment option by targeting a p... responsible for the devastating disease. , Appr...ectious viral disease known as HIV-AIDS. Although ...
..., WALNUT CREEK, -The genome analysis of a tiny gr...uniquely associated with carbon dioxide capture an...es revealed in the study are those that encode the...le that houses the photosynthetic apparatus, the c...ght to chemical energy. The genome also provides ...
Other Biology News:Nitrogen -- the silent species eliminator 2Nitrogen -- the silent species eliminator 3New class of drug offers hope to treatment-resistant AIDS patients 2New class of drug offers hope to treatment-resistant AIDS patients 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3
(Date:12/3/2009)... Shire plc (LSE: SHP, Nas...cal company, today announced a voluntary recall of...lot of the Attention-Deficit/Hyperactivity Disorde...his action because some Daytrana patches do not me...er removal specification, and as a result, patient...
(Date:12/3/2009)...c. 3 Caliper Life Scienc...ools and services for drug discovery and life scie...oftware for IVIS® in vivo imaging systems. Li...er IVIS systems currently installed in laboratorie...ectral unmixing tools to enhance fluorescent sensi...
(Date:12/2/2009)...c. 2 Spectrum Blue Steel is emergi...anies on the planet. Through the efforts of True G...t and Recycling Specialist Leroy Johnston, who has... stated that Spectrum Blue Steel is light years ah...acular earnings because of the bi products recover...
(Date:12/2/2009)... Reportlinker.com announces that a...talogue: ,, Drug Discovery Technologies - A Gl...,, http://www.reportlinker.com/p0164246/Drug-D...Trends--Opportunities.html ,, Drug discovery h... pharmaceutical company,s business strategy. There...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... is Cepheid,s Second FDA Cleared Diagnostic Test i...n Twenty-Four Hours Over Conventional ...t. 1 Cepheid (Nasdaq:,CPHD) today announced it ha...inistration (FDA) to market its Xpert(TM) MRSA/SA ...rt(R) System, for the detection of,Methicillin-res...
... October 1 , - "Expert Consult" Title Regularly I... Always Current, Elsevier, the leading publisher ... publication of the 40th edition of the most famou...y: The Anatomical Basis of Clinical,Practice ( htt...0443066849 ),in September 2008., In celebration o...
...if., Oct. 1 Lumiphore, Inc., a,biotechnology lead...nt,metal-lanthanide technology for use in high-val...xclusive agreement with Biophor Diagnostics, Inc.,...ts in diagnostic tests,for drugs of abuse., Under...usive worldwide,rights to Lumi4(TM) technology in ...
Other Biology Technology:Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 4Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 5New 40th Edition of Gray's Anatomy Celebrates 150 Years as the World's Preeminent Anatomical Reference 2New 40th Edition of Gray's Anatomy Celebrates 150 Years as the World's Preeminent Anatomical Reference 3Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board 2
Mouse Anti-Keap1 Monoclonal Antibody, Unconjugated, Clone 333116 from R&D Systems
Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON
Normal Guinea Pig Serum from Equitech-Bio
ELF 97 Cytological Labeling Kit *with streptavidin alkaline phosphatase conjugate* *50 assays* from Molecular Probes (Invitrogen)
Biology Products: